Biologics in food allergy: up-to-date

Area of Science:

• Immunology
• Allergy Research
• Pharmacology

Background:

• Immunotherapy has advanced IgE-mediated food allergy management.
• Existing treatment barriers necessitate novel therapeutic strategies.
• Understanding disease pathogenesis guides the development of new therapies.

Purpose of the Study:

• To review the role of biologics in treating IgE-mediated food allergy.
• To explore biologics targeting Th2 inflammatory pathways.
• To assess biologics as standalone or adjunctive therapies.

Main Methods:

• Review of preclinical studies and randomized controlled trials.
• Focus on monoclonal antibodies targeting IgE, IL-4/IL-13, IL-5, and alarmins.
• Analysis of biologics' impact on Th2 pro-inflammatory pathways.

Main Results:

• Biologics show demonstrated clinical efficacy and safety in food allergy.
• Agents targeting IgE, IL-4/IL-13, IL-5, and alarmins are under investigation.
• Biologics can modulate key inflammatory pathways involved in food allergy.

Conclusions:

• Biologics represent a promising therapeutic avenue for IgE-mediated food allergy.
• Further research is essential to establish optimal dosing and treatment protocols.
• Addressing unmet needs will enhance the effectiveness of biologic therapies.